MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury

Medical Hypotheses

Volumn 81, Issue 1, 2013, Pages 108-110

  Zhou, Mi ^a,b   Cai, Junfeng ^b   Tang, Yaoliang ^c   Zhao, Qiang ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 17 92; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; GENE CLUSTER; GENE EXPRESSION; GENE STRUCTURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPOTHESIS; MULTIGENE FAMILY; REGULATOR GENE; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; BASE SEQUENCE; GENES, REGULATOR; MICE; MICRORNAS; MODELS, THEORETICAL; MULTIGENE FAMILY; MYOCARDIAL REPERFUSION INJURY;

ANIMALIA; MUS;

EID: 84878592687     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.03.043     Document Type: Article

References (35)

1. Beaglehole R., Bonita R., Horton R., Adams O., McKee M. Public health in the new era: improving health through collective action. Lancet 2004, 363:2084-2086.
2. Baines C.P. How and when do myocytes die during ischemia and reperfusion: the late phase. J Cardiovasc Pharmacol Ther 2011, 16:239-243.
3. Rose B.A., Force T., Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010, 90:1507-1546.
4. Williams D.L., Ozment-Skelton T., Li C. Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006, 25:432-439.
5. Tekin D., Dursun A.D., Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin 2010, 31:1085-1094.
6. Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal 2009, 11:1913-1928.
7. Wu M.L., Ho Y.C., Yet S.F. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal 2011, 15:1835-1846.
8. Burger D., Xenocostas A., Feng Q.P. Molecular basis of cardioprotection by erythropoietin. Curr Mol Pharmacol 2009, 2:56-69.
9. Kim H.W., Haider H.K., Jiang S., Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009, 284:33161-33168.
10. Wang X., Zhang X., Ren X.P., Chen J., Liu H., Yang J., et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010, 122:1308-1318.
11. Hullinger T.G., Montgomery R.L., Seto A.G., Dickinson B.A., Semus H.M., Lynch J.M., et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 2012, 110:71-81.
12. Aurora A.B., Mahmoud A.I., Luo X., Johnson B.A., van Rooij E., Matsuzaki S., et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest 2012, 122:1222-1232.
13. Xiao J., Zhu X., He B., Zhang Y., Kang B., Wang Z., et al. MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II. J Biomed Sci 2011, 18:35.
14. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
15. Tagawa H., Karube K., Tsuzuki S., Ohshima K., Seto M. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 2007, 98:1482-1490.
16. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008, 9:405-414.
17. Doebele C., Bonauer A., Fischer A., Scholz A., Reiss Y., Urbich C., et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950.
18. Rao E., Jiang C., Ji M., Huang X., Iqbal J., Lenz G., et al. The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia 2012, 26:1064-1072.
19. Molitoris J.K., McColl K.S., Distelhorst C.W. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2011, 25:409-420.
20. Yan H.L., Xue G., Mei Q., Wang Y.Z., Ding F.X., Liu M.F., et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 2009, 28:2719-2732.
21. Dai B., Meng J., Peyton M., Girard L., Bornmann W.G., Ji L., et al. STAT3 mediates resistance to MEK inhibitor through microRNA miR-17. Cancer Res 2011, 71:3658-3668.
22. Fontana L., Fiori M.E., Albini S., Cifaldi L., Giovinazzi S., Forloni M., et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008, 3:e2236.
23. Yan H.J., Liu W.S., Sun W.H., Wu J., Ji M., Wang Q., Zheng X., Jiang J.T., Wu C.P. MiR-17-5p inhibitor enhances chemosensitivity to gemcitabine Via upregulating bim expression in pancreatic cancer cells. Dig Dis Sci 2012, 57:3160-3167.
24. Gibcus J.H., Kroesen B.J., Koster R., Halsema N., de Jong D., de Jong S., et al. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma. J Pathol 2011, 225:609-617.
25. Huang G., Nishimoto K., Zhou Z., Hughes D., Kleinerman E.S. MiR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 2012, 72:908-916.
26. Li Y., Tan W., Neo T.W., Aung M.O., Wasser S., Lim S.G., et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009, 100:1234-1242.
27. Fu X., Tian J., Zhang L., Chen Y., Hao Q. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett 2012, 586:1279-1286.
28. Pichiorri F., Suh S.S., Ladetto M., Kuehl M., Palumbo T., Drandi D., et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 2008, 105:12885-12890.
29. Mavrakis K.J., Wolfe A.L., Oricchio E., Palomero T., de Keersmaecker K., McJunkin K., et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2012, 12:372-379.
30. Liu M., Wang Z., Yang S., Zhang W., He S., Hu C., et al. TNF-alpha is a novel target of miR-19a. Int J Oncol 2011, 38:1013-1022.
31. Tsuchida A., Ohno S., Wu W., Borjigin N., Fujita K., Aoki T., et al. MiR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 2011, 102:2264-2271.
32. Zhang H., Zuo Z., Lu X., Wang L., Wang H., Zhu Z. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 2012, 27:594-598.
33. Gocek E., Wang X., Liu X., Liu C.G., Studzinski G.P. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res 2011, 71:6230-6239.
34. Razumilava N., Bronk S.F., Smoot R.L., Fingas C.D., Werneburg N.W., Roberts L.R., et al. MiR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 2012, 55:465-475.
35. Boggs R.M., Moody J.A., Long C.R., Tsai K.L., Murphy K.E. Identification, amplification and characterization of miR-17-92 from canine tissue. Gene 2007, 404:25-30.